Same Indication

Imatinib vs Sitagliptin

Imatinib vs Sitagliptin: Overview

This comparison examines the pharmacological differences between Imatinib and Sitagliptin.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Sitagliptin: DPP-4 inhibitor increasing incretin levels.

Pharmacokinetics

Half-life: Imatinib β€” 18 hours; Sitagliptin β€” 12.4 hours.

Chemical Properties

Molecular Formula: Imatinib β€” C29H31N7O; Sitagliptin β€” C16H15F6N5O.

Molecular Weight: Imatinib β€” 493.6030 g/mol; Sitagliptin β€” 407.3140 g/mol.

Type: Imatinib β€” Small molecule; Sitagliptin β€” Small molecule.